Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.
In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients.
This volume presents the latest research and recommendations on the definition, causes and therapy of treatment-resistant schizophrenia (TRS). Methods for identification and optimal management of TRS are reviewed.
In addition, the book discusses the benefit of antipsychotic medication in a range of therapeutic indications, and demonstrates the gain in life-expectancy associated with clozapine use in severe mental illness despite its serious, ...
Neurobiology, Clinical Course, and Therapeutic Approaches of Treatment Resistant Schizophrenia: Toward an Integrated View
The book was originally commissioned with the intention of creating a comprehensive text focusing on treatment-resistant schizophrenia and its management.
Sylvia expressed that she was reluctant to attend things because she had insufficient time to complete the household chores and support her son with his medication. ... Hitherto, Sylvia would prepare a cooked egg breakfast for her son.
Oliver Wendell Holmes, Sr., an admired physician and writer from New England, challenged the unspoken assumption that drugs are potentially useful unless proven otherwise (in his days, the challenge was homeopathy) and suggested instead ...
Talking cures and placebo effects. Oxford: Oxford University Press; 2008. Jaksic N, Aukst-Margetic B, Jakovljevic M. Does personality play a relevant role in the placebo effect? Psychiatr Danub. 2013;25:17–23. Benedetti F. Placebo ...
Developed by experts on schizophrenia and exhaustively reviewed by APA members, the "American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia" provides therapists with a set of patient care ...
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons ...